CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 9.42: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
591.14MUSDvs all stocks (USD)
Revenue (TTM)
52.40MUSDvs all stocks (USD)
Profit Margin
-23.72%vs Medical Devices peers
Beta
0.5820xvs all stocks
52-Week Change
-48.58%vs all stocks
Market Capitalization
591.14MUSDvs all stocks (USD)
Enterprise Value
595.36MUSDvs all stocks (USD)
Forward P/E
-49.17xvs Medical Devices peers
Price to Sales (TTM)
11.28xvs Medical Devices peers
Price to Book (MRQ)
10.85xvs Medical Devices peers
Enterprise to Revenue
11.36xvs Medical Devices peers
Enterprise to EBITDA
-82.80xvs Medical Devices peers
Gross Margin
50.94%vs Medical Devices peers
Profit Margin
-23.72%vs Medical Devices peers
Operating Margin
-16.29%vs Medical Devices peers
Return on Assets (TTM)
-6.34%vs Medical Devices peers
Return on Equity (TTM)
-26.06%vs Medical Devices peers
Revenue (TTM)
52.40MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.2670USDUpdated Sep 28, 2026Quarterly Revenue Growth
39.40%vs Medical Devices peers
Gross Profit (TTM)
24.97MUSDvs all stocks (USD)
EBITDA (TTM)
-7.19MUSDvs all stocks (USD)
Net Income (TTM)
-12.43MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
39.39%vs Medical Devices peers
Operating Cash Flow (TTM)
-15.53MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-3.90MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
42.48MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
22.94MUSDFY2025 · Dec 31, 2025Gross Profit
19.54MUSDFY2025 · Dec 31, 2025Operating Income
-8.19MUSDvs all stocks (USD)
Pre-tax Income
-8.16MUSDFY2025 · Dec 31, 2025Income Tax Expense
3.97MUSDFY2025 · Dec 31, 2025Net Income
-12.13MUSDFY2025 · Dec 31, 2025EBIT
-7.05MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-5.98MUSDFY2025 · Dec 31, 2025Research & Development
3.69MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
22.98MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
1.14MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
1.11MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.0600USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.0600USDFY2025 · Dec 31, 2025Basic Shares Outstanding
190.01MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
190.01MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-12.13MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-18.03MUSDFY2025 · Dec 31, 2025Free Cash Flow
-21.69MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
9.60MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-12.13MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.08MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-512.87KUSDFY2025 · Dec 31, 2025Stock-based Compensation
8.13MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-318.89KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-13.04MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
2.88MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-4.12MUSDFY2025 · Dec 31, 2025Capital Expenditures
-3.66MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-3.66MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
28.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-5.28MUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
3.45MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
26.17MUSDFY2025 · Dec 31, 2025Shares Outstanding
200.17MSharesUpdated Sep 28, 2026Float Shares
40.62MSharesUpdated Sep 28, 2026Shares Short
59.66KSharesUpdated Sep 28, 2026Short Ratio
1.20daysvs all stocks
Short % of Shares Outstanding
0.11%vs all stocks
% Held by Insiders
80.11%vs all stocks
% Held by Institutions
0.85%vs all stocks
Total Cash (MRQ)
13.65MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.0680USDUpdated Sep 28, 2026Total Debt (MRQ)
17.87MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.3347xvs Medical Devices peers
Current Ratio (MRQ)
2.24xvs Medical Devices peers
Book Value per Share (MRQ)
0.2720USDUpdated Sep 28, 2026Total Assets
74.23MUSDvs all stocks (USD)
Total Current Assets
48.80MUSDFY2025 · Dec 31, 2025Total Liabilities
36.01MUSDFY2025 · Dec 31, 2025Total Non-current Assets
25.43MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
9.77MUSDFY2025 · Dec 31, 2025Total Current Liabilities
26.24MUSDFY2025 · Dec 31, 2025Cash
3.21MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.21MUSDFY2025 · Dec 31, 2025Accounts Receivable
12.40MUSDFY2025 · Dec 31, 2025Inventory
17.06MUSDFY2025 · Dec 31, 2025Accounts Payable
5.13MUSDFY2025 · Dec 31, 2025Short-term Debt
12.02MUSDFY2025 · Dec 31, 2025Deferred Revenue
3.27MUSDFY2025 · Dec 31, 2025Long-term Debt
2.34MUSDFY2025 · Dec 31, 2025Common Stock (Book)
19.42KUSDFY2025 · Dec 31, 2025Retained Earnings
-55.79MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
38.22MUSDvs all stocks (USD)
52-Week Low
2.87USDUpdated Sep 28, 202652-Week High
10.00USDUpdated Sep 28, 202652-Week Change
-48.58%vs all stocks
Beta
0.5820xvs all stocks
50-Day MA
3.54USDUpdated Sep 28, 2026200-Day MA
4.26USDUpdated Sep 28, 2026Avg 10-Day Volume
80.32KSharesUpdated Sep 28, 2026Avg 30-Day Volume
57.21KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
-0.0600USDUpdated Sep 28, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.51Profit Margin: -0.24
Financial Health
Altman Z-Score 9.42: safe zoneNotable
Altman Z-Score: 9.42
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shandong Wohua Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Phathom Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Gkht Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
OrthoPediatrics Corp.
Tier 1ProductionApproval-Gated PipelineRule
CytomX Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tibet Weixinkang Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Aquestive Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Altimmune, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Sihuan Bioengineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Beijing Bohui Innovation Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow